EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase IV)

Renal perfusion with histidine-tryptophan-ketoglutarate compared with Ringer's solution in patients undergoing thoracoabdominal aortic open repair

Andrea Kahlberg, Yamume Tshomba, Domenico Baccellieri, Luca Bertoglio, Enrico Rinaldi, Vincenzo Ardita, Elisa Colombo, Umberto Moscato, Germano Melissano, Roberto Chiesa, CURITIBA Investigators

The Journal of Thoracic and Cardiovascular Surgery · 2023-02 · 165 (2) · 569-579.e5

DOI: 10.1016/j.jtcvs.2021.02.090 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2023-02. Verfasst von Andrea Kahlberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Vita-Salute University School of Medicine, San Raffaele Scientific Institute, Milano, Italy. Electronic address: kahl…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Aortic Aneurysm, Thoracic. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The objective of this study was to compare the efficacy of renal perfusion with Custodiol (Dr Franz-Kohler Chemie GmbH, Bensheim, Germany) versus enriched Ringer's solution for renal protection in patients undergoing open thoracoabdominal aortic aneurysm (TAAA) repair. METHODS: Ninety consecutive patients scheduled for elective open TAAA repair were enrolled between 2015 and 2017 in a single-center, phase IV, prospective, parallel, randomized, double-blind trial (the CUstodiol versus RInger: whaT Is the Best Agent [CURITIBA] trial), and randomized to renal arteries perfusion with 4°C Custodiol (Dr Franz-Kohler Chemie GmbH, Bensheim, Germany; n = 45) or 4°C lactated Ringer's solution (n = 45). The incidence of acute kidney injury (AKI) in patients undergoing TAAA open surgery using Custodiol renal perfusion versus an enriched Ringer's solution was the primary end point. RESULTS: Ninety patients completed the study (45 patients in each group). The incidence of postoperative AKI was significantly lower in the Custodiol group (48.9% vs 75.6%; P = .02). In the multivariable model, only the use of Custodiol solution resulted as protective from the occurrence of any AKI (odds ratio, 0.230; 95% confidence interval, 0.086-0.614; P = .003), whereas TAAA type II extent was associated with the development of severe AKI (odds ratio, 4.277; 95% confidence interval, 1.239-14.762; P = .02). At 1-year follow-up, serum creatinine was not significantly different from the preoperative values in both groups. CONCLUSIONS: The use of Custodiol during open TAAA repair was safe and resulted in significantly lower rates of postoperative AKI compared with Ringer's solution. These findings support safety and efficacy of Custodiol in this specific setting, which is currently off-label.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryAortic Aneurysm, ThoracicHumansRinger's SolutionHistidineTryptophanProspective StudiesPerfusionTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

Custodiol solutionacute kidney injurychronic kidney disease stageenriched Ringer'sthoracoabdominal aortic aneurysm

Substanzen

Ringer's SolutionHistidineTryptophan

Autor:innen und Institutionen

  • Department of Vascular Surgery, Vita-Salute University School of Medicine, San Raffaele Scientific Institute, Milano, Italy. Electronic address: kahlberg.andrea@hsr.it.
  • Vascular Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Department of Vascular Surgery, Vita-Salute University School of Medicine, San Raffaele Scientific Institute, Milano, Italy.
  • Department of Women's Health, Child and Public Health Sciences, Hospital Hygiene - and Occupational Health - Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.

Zitieren

APA

Kahlberg, A., Tshomba, Y., Baccellieri, D., Bertoglio, L., Rinaldi, E., Ardita, V., Colombo, E., Moscato, U., Melissano, G., Chiesa, R., & CURITIBA Investigators (2023). Renal perfusion with histidine-tryptophan-ketoglutarate compared with Ringer's solution in patients undergoing thoracoabdominal aortic open repair. The Journal of Thoracic and Cardiovascular Surgery, 165(2), 569-579.e5. https://doi.org/10.1016/j.jtcvs.2021.02.090

Vancouver

Kahlberg A, Tshomba Y, Baccellieri D, Bertoglio L, Rinaldi E, Ardita V, et al. Renal perfusion with histidine-tryptophan-ketoglutarate compared with Ringer's solution in patients undergoing thoracoabdominal aortic open repair. The Journal of Thoracic and Cardiovascular Surgery. 2023;165(2):569-579.e5. doi:10.1016/j.jtcvs.2021.02.090

BibTeX
@article{Kahlberg2023,
  author = {Kahlberg, Andrea and Tshomba, Yamume and Baccellieri, Domenico and Bertoglio, Luca and Rinaldi, Enrico and Ardita, Vincenzo and Colombo, Elisa and Moscato, Umberto and Melissano, Germano and Chiesa, Roberto and CURITIBA Investigators, CURITIBA Investigators},
  title = {Renal perfusion with histidine-tryptophan-ketoglutarate compared with Ringer's solution in patients undergoing thoracoabdominal aortic open repair},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2023},
  volume = {165},
  number = {2},
  pages = {569--579.e5},
  doi = {10.1016/j.jtcvs.2021.02.090}
}
Kostenlos starten →